Qian_2020_Drug.Metab.Dispos_48_993

Reference

Title : Natural Products as Modulators of CES1 Activity - Qian_2020_Drug.Metab.Dispos_48_993
Author(s) : Qian Y , Markowitz JS
Ref : Drug Metabolism & Disposition: The Biological Fate of Chemicals , 48 :993 , 2020
Abstract : Carboxylesterase (CES) 1 is the predominant esterase expressed in the human liver and is capable of catalyzing the hydrolysis of a wide range of therapeutic agents, toxins, and endogenous compounds. Accumulating studies have demonstrated associations between the expression and activity of CES1 and the pharmacokinetics and/or pharmacodynamics of CES1 substrate medications (e.g., methylphenidate, clopidogrel, oseltamivir). Therefore, any perturbation of CES1 by coingested xenobiotics could potentially compromise treatment. Natural products are known to alter drug disposition by modulating cytochrome P450 and UDP-glucuronosyltransferase enzymes, but this issue is less thoroughly explored with CES1. We report the results of a systematic literature search and discuss natural products as potential modulators of CES1 activity. The majority of research reports reviewed were in vitro investigations that require further confirmation through clinical study. Cannabis products (delta (9)-tetrahydrocannabinol, cannabidiol, cannabinol); supplements from various plant sources containing naringenin, quercetin, luteolin, oleanolic acid, and asiatic acid; and certain traditional medicines (danshen and zhizhuwan) appear to pose the highest inhibition potential. In addition, ursolic acid, gambogic acid, and glycyrrhetic acid, if delivered intravenously, may attain high enough systemic concentrations to significantly inhibit CES1. The provision of a translational interpretation of in vitro assessments of natural product actions and interactions is limited by the dearth of basic pharmacokinetic data of the natural compounds exhibiting potent in vitro influences on CES1 activity. This is a major impediment to assigning even potential clinical significance. The modulatory effects on CES1 expression after chronic exposure to natural products warrants further investigation. SIGNIFICANCE STATEMENT: Modulation of CES1 activity by natural products may alter the course of treatment and clinical outcome. In this review, we have summarized the natural products that can potentially interact with CES1 substrate medications. We have also noted the limitations of existing reports and outlined challenges and future directions in this field.
ESTHER : Qian_2020_Drug.Metab.Dispos_48_993
PubMedSearch : Qian_2020_Drug.Metab.Dispos_48_993
PubMedID: 32591414

Related information

Citations formats

Qian Y, Markowitz JS (2020)
Natural Products as Modulators of CES1 Activity
Drug Metabolism & Disposition: The Biological Fate of Chemicals 48 :993

Qian Y, Markowitz JS (2020)
Drug Metabolism & Disposition: The Biological Fate of Chemicals 48 :993